• About Us
    • Leadership
    • Our Supporters
    • IRS Form 990
  • Resources for Your Journey
    • What Is Heart Valve Disease?
  • News & Insights
    • HVV US Patient Journey Report
  • Advocacy
    • HVD Policy Task Force
    • #Ask4Echo Campaign
  • Join Our Community
    • Sign Up For Our Mailing List
    • My Valve. My Voice.
Heart Valve Voice USHeart Valve Voice US
  • About Us
    • Leadership
    • Our Supporters
    • IRS Form 990
  • Resources for Your Journey
    • What Is Heart Valve Disease?
  • News & Insights
    • HVV US Patient Journey Report
  • Advocacy
    • HVD Policy Task Force
    • #Ask4Echo Campaign
  • Join Our Community
    • Sign Up For Our Mailing List
    • My Valve. My Voice.

CMS Decision on TAVR Puts Patients at the End of the Line

June 24, 2019 Policy Archives

The Centers for Medicaid and Medicare Services today issued their final National Coverage Decision on how hospitals will be approved to do the TAVR (transaortic valve replacement) procedure, a less invasive valve replacement treatment that avoids open heart surgery and allows patients to resume daily life more quickly.

“CMS’s decision to judge hospitals on volume, rather then quality outcomes, will further deny patient access to this innovative procedure. This is despite seven years of data showing that lower volume hospitals and higher volume hospitals have nearly equal outcomes,” said Lisa M Tate, interim executive director for Heart Valve Voice.

“Seniors living in rural areas, African Americans and Hispanics are particularly impacted by today’s decision. The majority of hospitals that offer TAVR will continue to primarily be urban teaching hospitals. Currently, of more than 80,000 TAVR procedures conducted in the U.S., 95% of patients have been white and 70% lived in higher income zip codes.

CMS’ decision will only exacerbate the already great disparities in who will have access to TAVR.”

Heart Valve Voice is a nonprofit patient education and advocacy organization for people living with heart valve disease.

Tags: CMSTAVR
Share
0

You also might be interested in

CMS Makes Progress but Continues to Limit Life-Saving Access for Heart Valve Disease Patients

CMS Makes Progress but Continues to Limit Life-Saving Access for Heart Valve Disease Patients

Mar 28, 2019

Washington, D.C., March 27, 2019 – Below is a statement issued on[...]

Watch Our Webinar: What You Need to Know About Medicare’s Proposed TAVR Decision and How to Lend Your Voice to Make a Difference

Apr 16, 2019

Did you miss our webinar on April 16th, 2019? You[...]

Elderly heart valve patients willing to accept more risks from treatment options to maintain independence

Jun 17, 2019

New study finds that elderly patients would tolerate substantially more[...]

Contact Us

Please contact us with any questions or to get involved.

Send Message
Join the My Valve My Voice patient community Download the app
Sign Up for Our Mailing List

© · Heart Valve Voice

Terms of Use
Privacy Policy

Contact Info

  • Heart Valve Voice US
  • 100 M Street SE 600 Washington, DC 20003
  • info@heartvalvevoice-us.org
  • https://www.heartvalvevoice-us.org
Prev Next